Eric Wang
- Hematology top 1%
- Acute Myeloid Leukemia Research 9
- Molecular Biology top 2%
- Protein Degradation and Inhibitors 11
- RNA Research and Splicing 7
- Histone Deacetylase Inhibitors Research 6
- RNA and protein synthesis mechanisms 5
- RNA modifications and cancer 4
- CRISPR and Genetic Engineering 4
- Epigenetics and DNA Methylation 3
- Aging top 5%
- Cancer Research top 5%
- Oncology top 10%
- Co-authors
- Christopher R. VakocJunwei ShiJohannes ZuberAmy RappaportIannis AifantisMeredith J. TaylorJoseph P. MilazzoJustin B. Kinney
- Cited by
- HematologyMolecular BiologyAging
- Partner nations
- United StatesAustriaJapan
In The Last Decade
Eric Wang
35 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Hematology 1.0k
- Molecular Biology 3.2k
- Aging 49
- Cancer Research 320
- Oncology 435
Countries citing papers authored by Eric Wang
This map shows the geographic impact of Eric Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wang more than expected).
Fields of papers citing papers by Eric Wang
This network shows the impact of papers produced by Eric Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wang. The network helps show where Eric Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 53 | |
| 6 | 2022 | 26 | |
| 7 | 2022 | 21 | |
| 8 | 2021 | 35 | |
| 9 | 2020 | 142 | |
| 10 | 2019 | 214 | |
| 11 | 2017 | 45 | |
| 12 | 2015 | 109 | |
| 13 | Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domainsbreakdown → | 2015 | 500 |
| 14 | 2013 | 45 | |
| 15 | 2013 | 302 | |
| 16 | 2012 | 95 | |
| 17 | 2011 | 207 | |
| 18 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiabreakdown → | 2011 | 1438 |
| 19 | 2009 | 157 | |
| 20 | 1998 | 23 |
About Eric Wang
Eric Wang is a scholar working on Aging, Hematology and Molecular Biology, having authored 36 papers that have together received 3.8k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (11 papers), Acute Myeloid Leukemia Research (9 papers), RNA Research and Splicing (7 papers), Histone Deacetylase Inhibitors Research (6 papers), RNA and protein synthesis mechanisms (5 papers), RNA modifications and cancer (4 papers), CRISPR and Genetic Engineering (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Hematology (1.0k citations), Molecular Biology (3.2k citations) and Aging (49 citations). Eric Wang has collaborated with scholars based in United States, Austria and Japan. Frequent co-authors include Christopher R. Vakoc, Junwei Shi, Johannes Zuber, Amy Rappaport, Iannis Aifantis, Meredith J. Taylor, Joseph P. Milazzo, Justin B. Kinney, Scott C. Kogan and Scott W. Lowe. Their work appears in journals such as Blood, Molecular Cell, Nature, Nature Biotechnology and Trends in cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.